Friday, July 10, 2026

Drug profile · INN

nicorandil

nicorandil (IKOTAB) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

TGA: approved
Patents linked 3
Pipeline programs 4
News articles 0
Drug details — nicorandil

Quick answer

nicorandil (IKOTAB) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

Key facts

INN nicorandil
Brand IKOTAB

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. Nicorandil Approved · Chinese Academy of · Non-obstructive Coronary Artery Disease
  2. Nicorandil Approved · Chinese Academy of · Stable Angina
  3. Nicorandil 5mg tid Approved · Chinese Academy of · Coronary Artery Bypass Graft
  4. nicorandil Approved · Chinese Academy of · STEMI - ST-segment Elevation Myocardial Infarction
  1. US 12396989

    Nicorandil derivatives

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 12377082

    Nicorandil derivatives

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 12036211

    Nicorandil derivatives

    Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is nicorandil?

nicorandil (IKOTAB) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

What is the brand name for nicorandil?

IKOTAB is a marketed brand name for nicorandil. Check FDA Drugs@FDA for the current US label holder and prescribing information.